Ποια είναι η τιμή για Telo Genomics Corp. (TELO)

Η τιμή για Telo Genomics Corp. (TELO) είναι $0.03302716

Ποια είναι η κεφαλαιοποίηση αγοράς για Telo Genomics Corp. (TELO)

Η κεφαλαιοποίηση αγοράς για Telo Genomics Corp. (TELO) είναι $3.32M

Telo Genomics Corp. (TELO) Τιμή και Κεφαλαιοποίηση Αγοράς

Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.

Η τιμή για TELO	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$54,282.96 $3.32M	NVDA	$5.452T	+164,358,437.43%
$44,706.07 $3.32M	AAPL	$4.490T	+135,361,428.22%
$41,444.10 $3.32M	GOOG	$4.162T	+125,484,809.62%
$36,604.47 $3.32M	MSFT	$3.676T	+110,831,324.38%
$28,207.94 $3.32M	AMZN	$2.833T	+85,408,197.71%

Η τιμή για TELO

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$54,282.96 $3.32M